Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Haoxi Health TechnologyHAO -13.06%21 14-Day RSI is 19.06 as of Aug. 19, 2026. GuruFocus rates HAO with a GF Score™ of 21/100. The stock has 5 warning signs investors should review. Among 1,045 Media - Diversified companies, Haoxi Health Technology ranks better than 98.28% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
Haoxi Health Technology (NAS:HAO) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Haoxi Health Technology 14-Day RSI Related Terms
HAO vs BAOS, DBMM, DRCT: 14-Day RSI Comparison
For the Advertising Agencies subindustry, Haoxi Health Technology's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haoxi Health Technology 14-Day RSI vs Media - Diversified Industry
For the Media - Diversified industry and Communication Services sector, Haoxi Health Technology's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Haoxi Health Technology's 14-Day RSI falls into.
Haoxi Health Technology (NAS:HAO) 14-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haoxi Health Technology (HAO) has a 14-Day RSI of 19.06 as of Aug. 19, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Haoxi Health Technology and its competitors. According to the industry distribution chart, Haoxi Health Technology ranks #18 out of 1045 companies in the Media - Diversified industry, placing it in the top 1.7%.
Is Haoxi Health Technology's 14-Day RSI too high?
Haoxi Health Technology's current 14-Day RSI is 19.06. The Media - Diversified industry median 14-Day RSI is 49.39. Haoxi Health Technology's value of 19.06 is 61.4% below this industry median. Based on the distribution chart, Haoxi Health Technology ranks #18 out of 1045 companies in the Media - Diversified industry, which is in the top quartile — a strong position relative to peers. Overall, Haoxi Health Technology has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Haoxi Health Technology's 14-Day RSI compare to BAOS and DBMM?
According to the Media - Diversified industry distribution chart, Haoxi Health Technology ranks #18 out of 1045 companies for 14-Day RSI. This places Haoxi Health Technology in the top 2% of its industry — outperforming the majority of peers. The industry median 14-Day RSI is 49.39. Haoxi Health Technology's value of 19.06 is 61.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Media - Diversified company?
The median 14-Day RSI among Media - Diversified companies is 49.39, based on 1,045 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Haoxi Health Technology's current 14-Day RSI of 19.06 is 61.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Haoxi Health Technology and its competitors. For the Media - Diversified industry, the median 14-Day RSI is 49.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Haoxi Health Technology's current 14-Day RSI is 19.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haoxi Health Technology stock overvalued right now?
Haoxi Health Technology (HAO) has a current 14-Day RSI of 19.06. The current 14-Day RSI is 19.06 and 61.4% below the Media - Diversified industry median of 49.39. Haoxi Health Technology's overall GF Score™ is 21/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Haoxi Health Technology (HAO), the current 14-Day RSI is 19.06 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. The company offers services that include planning, producing, placing, and optimizing online ads especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms. It places advertisements on popular digital platforms such as Toutiao, Douyin, WeChat, and Sina Weibo through media partners. Revenue is generated by providing comprehensive online marketing solutions. The company's operations center on digital advertising via mainstream video and social media channels in the Chinese market.
21GF Score
Get the complete analysis for HAO
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAO has been successfully added to your 
